…149; free full text at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979887/pdf/yic-29-138.pdf). Both study doses were superior to placebo in mean change from baseline in MADRS total score at 8 weeks; the mean treatment difference was -5.5 points with the 15-mg dose and -7.1 points with the 20-mg dose. The treatment discontinuation rate was 22.5% and 17.2% with vortioxetine 15 mg and 20 mg versus 15.8% with placebo. The most common adverse effects…
…s in MS research, and to refer their MS patients to MSology to learn more about their disease. To access the site, go to www.MSology.com….
…ins et al. BMC Psychiatry 2013;13:318, free full text at www.biomedcentral.com/content/pdf/1471-244X-13-318.pdf). The latest alternative to face time is Facebook. A new study has examined whether joining Facebook – and specifically “friending” the psychiatrist – is beneficial in patients with treatment-resistant depression (Mota Pereira J. Scientific World J 2014;2014:892048; free full text at www.ncbi.nlm.nih.gov/pmc/articles/PMC3916106/pdf/TSWJ2…
…(Charlson et al. BMC Med 2013;11:250; free full text at www.biomedcentral.com/content/pdf/1741-7015-11-250.pdf). Depressive disorders are the leading contributor to disability-adjusted life years (DALY), and the second-leading cause of YLD (Ferrari et al. PLoS Med 2013;10:e1001547; free full text at www.ncbi.nlm.nih.gov/pmc/articles/PMC3818162/pdf/pmed.1001547.pdf). The greatest burden is seen in depressive disorders, followed by anxiety disorder…
…ut four-fold longer than first-concussion patients. To view the AAN’s current guidelines on the evaluation and management of concussion in sport, see Giza et al. Neurology 2013;80:2250-2257; free full text at www.neurology.org/content/80/24/2250.full). Guest Reviewer: Dr. Daniel Selchen, Head of Neurology, St. Michael’s Hospital, Toronto, Canada…